Cause of death, by non-communicable diseases, ages 5-14, female in Japan
Japan: Cause of death, by non-communicable diseases, ages 5-14, female was 62.9% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 5-14, female in Japan, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total female deaths ages 5-14.
Analysis
Japan recorded 62.9% for cause of death, by non-communicable diseases, ages 5-14, female in 2021.
Compared with earlier readings it is up 5.5% on the previous year and up 0.1% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 5-14, female in Japan peaked at 65.5% in 2015 and was at its lowest, 57.4%, in 2000.
That places Japan 30th out of 184 countries with data for 2021, putting it in the top quarter.
Cause of death, by non-communicable diseases, ages 5-14, female in Japan, year by year
| Year | % of total female deaths ages 5-14 | Change |
|---|---|---|
| 2000 | 57.4% | — |
| 2010 | 62.8% | +9.5% |
| 2015 | 65.5% | +4.3% |
| 2019 | 62.7% | -4.3% |
| 2020 | 59.6% | -5.0% |
| 2021 | 62.9% | +5.5% |
Japan compared with similar countries
- Japan's 62.9% is above the median for high income countries, which is 61.7%, 1.0× the median. (57 countries reporting)
- Japan's 62.9% is above the median for East Asia & Pacific, which is 36.9%, 1.7× the median. (26 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 57.4% | 57.4% | 57.4% | 1 |
| 2010s | 63.7% | 62.7% | 65.5% | 3 |
| 2020s | 61.2% | 59.6% | 62.9% | 2 |
Countries ranked near Japan
More health data for Japan
- Un projection of annual infant deaths, annual growth rate -2.73 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.2774 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,294 deaths per 1,000 people (2090)
- Number of infants who die before age 1 178 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.22 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0155 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.36 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 5-14, female in Japan?
- Cause of death, by non-communicable diseases, ages 5-14, female in Japan was 62.9% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 5-14, female recorded in Japan?
- The highest recorded value was 65.5% in 2015.
- What is the lowest cause of death, by non-communicable diseases, ages 5-14, female recorded in Japan?
- The lowest recorded value was 57.4% in 2000.
- How does Japan rank for cause of death, by non-communicable diseases, ages 5-14, female?
- Japan ranks 30th out of 184 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 5-14, female rising or falling in Japan?
- Over the last ten years it is up 0.1%. The long-run trend across the full record is rising.
- Where does this Japan data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 5-14, female (% of total female deaths ages 5-14). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of female deaths ages 5-14 due to non-communicable diseases divided by number of all female deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.